William Fodor
Chief Tech/Sci/R&D Officer at HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.
Net worth: - $ as of 2024-03-30
Profile
William Fodor is the Chief Scientific Officer at Harvard Apparatus Regenerative Technology, Inc. He was previously the Chief Executive Officer at GlyGenix Therapeutics, Inc. and a Senior Director at Alexion Pharmaceuticals, Inc. He also held positions as a Senior Director at ViaCell, Inc. and an Associate Professor at the University of Connecticut.
Fodor earned a doctorate degree from The Ohio State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-05-29 | 0 ( -.--% ) | - $ | 2024-03-30 |
William Fodor active positions
| Companies | Position | Start |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Chief Tech/Sci/R&D Officer | 2017-06-30 |
Former positions of William Fodor
| Companies | Position | End |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2008-06-30 |
| University of Connecticut | Corporate Officer/Principal | 2005-11-30 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Chief Executive Officer | - |
Training of William Fodor
| The Ohio State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
| Private companies | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Health Technology |
- Stock Market
- Insiders
- William Fodor
